|
|
| | Paroxetine EP IMpurity G Basic information |
| Product Name: | Paroxetine EP IMpurity G | | Synonyms: | Pyridine,4-(4-fluorophenyl)-1,2,3,6-tetrahydro-1-methyl-;Paroxetine EP IMpurity G;Paroxetine USP RC E;4-(4-fluorophenyl)-1-methyl-3,6-dihydro-2H-pyridine;Paroxetine HCl Hemihydrate EP Impurity G;Paroxetine Impurity 1(Paroxetine HCl Hemihydrate EP Impurity G);Paroxetine impurity G;Paroxetine Hydrochloride Anhydrous EP Impurity G | | CAS: | 69675-10-1 | | MF: | C12H14FN | | MW: | 191.24 | | EINECS: | | | Product Categories: | | | Mol File: | 69675-10-1.mol |  |
| | Paroxetine EP IMpurity G Chemical Properties |
| Boiling point | 264.5±40.0 °C(Predicted) | | density | 1.079±0.06 g/cm3(Predicted) | | storage temp. | under inert gas (nitrogen or Argon) at 2-8°C | | pka | 8.63±0.40(Predicted) |
| | Paroxetine EP IMpurity G Usage And Synthesis |
| Uses | 4-(4-Fluorophenyl)-1,2,3,6-tetrahydro-1-methylpyridine (Paroxetine EP Impurity G) is a 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs which inhibit the oxidation of benyzlamine by bovine plasma amine oxidase. Suitable as substrates for monoamine oxidase B and possesses dopaminergic neurotoxicity. |
| | Paroxetine EP IMpurity G Preparation Products And Raw materials |
|